The essentials
Military launches testosterone screening program as FDA loosens prescribing restrictions on hormone therapy.
The Defense Department has announced an annual testosterone screening program for military personnel, while the FDA simultaneously moves to ease prescribing limits on testosterone medications and remove boxed warnings from testosterone products.
The policy shift follows NIH research indicating testosterone improves certain sexual functions in older men. The initiatives expand access to hormone therapy across the military health system.
The changes occur against a backdrop of documented testosterone use in military units. A 2022 Navy SEAL recruit death revealed testosterone use in special operations, raising questions about substance use protocols within elite forces.
These concurrent regulatory and policy moves represent a significant liberalization of testosterone access within the U.S. military health framework.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
Regulatory and military actions converge on testosterone access
Defense Secretary Hegseth's announcement of annual screening coincides with FDA actions to ease prescribing limits and remove boxed warnings on testosterone products. NIH studies on testosterone efficacy provide the scientific backdrop. A 2022 incident involving a Navy SEAL recruit's death during testosterone use preceded these expanded access measures, suggesting a shift in institutional approach to hormone therapy.
Testosterone access expands within military and civilian health systems
The FDA's removal of boxed warnings and easing of prescribing limits reflects changing regulatory assessment of testosterone medications. Simultaneously, NIH research documenting testosterone's effects on sexual function in older men supports broader medical applications. The military's annual screening program operationalizes access within its personnel healthcare structure, creating parallel pathways for testosterone therapy across military and civilian contexts.